Combined Menin inhibitor and potent Ikaros degrader treatment strongly increased toxicity in leukemia cells and allowed for curative treatment of PDX, including a PDX model which had been demonstrated to succumb from MEN1‐mutant resistant leukemia after a relatively short latency.128. Here, MEN1 is linked to leukemia.